Nephro-Urology Monthly

Published by: Kowsar

Prevention and Treatment of CKD-MBD

Mario Cozzolino 1 , *
Author Information
1 Laboratory of Experimental Nephrology, Renal Division, University of Milan, San Paolo Hospital, Milan, Italy
Article information
  • Nephro-Urology Monthly: March 01, 2013, 5 (2); 773-4
  • Published Online: March 30, 2013
  • Article Type: Letter
  • Received: November 30, 2012
  • Accepted: December 8, 2012
  • DOI: 10.5812/numonthly.9372

To Cite: Cozzolino M. Prevention and Treatment of CKD-MBD, Nephro-Urol Mon. 2013 ;5(2):773-4. doi: 10.5812/numonthly.9372.

Copyright © 2013, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Bhan I, Thadhani R. Vascular calcification and ESRD: a hard target. Clin J Am Soc Nephrol. 2009; 4 Suppl 1-5[DOI][PubMed]
  • 2. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009; 20(7): 1453-64[DOI][PubMed]
  • 3. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003; 18(9): 1731-40[PubMed]
  • 4. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial. 2007; 20(2): 103-9[DOI][PubMed]
  • 5. Norman PE, Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol. 2005; 25(1): 39-46[DOI][PubMed]
  • 6. Marangella M, Berutti S, Fabbrini L. [Selective vitamin D receptor activation: effect on renal physiopathology]. G Ital Nefrol. 2009; 26 Suppl 49-9[PubMed]
  • 7. Cozzolino M, Ciceri P, Volpi EM, Olivi L, Messa PG. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease. Blood Purif. 2009; 27(4): 338-44[DOI][PubMed]
  • 8. Cozzolino M, Brenna I, Volpi E, Ciceri P, Mehmeti F, Cusi D. Restoring the physiology of vitamin D receptor activation and the concept of selectivity. Contrib Nephrol. 2011; 171: 151-6[DOI][PubMed]
  • 9. Brancaccio D, Bellasi A, Cozzolino M, Galassi A, Gallieni M. Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification. Curr Vasc Pharmacol. 2009; 7(3): 374-80[PubMed]
  • 10. Seck SM, Dahaba M, Ka EF, Cisse M, Gueye S, Tal AL. Mineral and bone disease in black African hemodialysis patients: a report from Senegal. Nephro-Urol Mon. 2012; 4(4): 613-161
  • 11. Berl T, Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol. 2006; 1(1): 8-18[DOI][PubMed]
  • 12. Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006; 69(1): 33-43[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments